Colchicine potentially manages inflammation in ischemic heart diseases through disrupting AKT/NF-κB signaling: A proposed mechanism from computational simulations

نویسندگان
doi
10.48309/jmpcr.2026.530247.1740
چکیده

Colchicine is a promising anti-inflammatory agent for ischemic conditions driven by excessive immune activation. NF-κB, a central inflammation regulator, may elucidate colchicine’s therapeutic mechanism in ischemic states. However, its molecular interactions in ischemic heart disease (IHD) remain poorly understood. We investigated colchicine’s interaction with NF-κB and its associated inflammatory targets, such as AKT-1 and IRAK-1, through in silico studies. To achieve the goal, molecular docking was used to assess the binding pattern and affinity of colchicine against NF-κB, AKT-1, and IRAK-1, using each target’s native ligand for reference. Molecular dynamics simulation was then performed to complement the docking analysis by evaluating complex stability under solvation, entropic, and physiological conditions. Docking analysis revealed binding affinities of -6.872 kcal/mol for AKT-1, -6.158 kcal/mol for IRAK-1, and -3.666 kcal/mol for NF-κB, indicating weaker binding compared to reference inhibitors. While colchicine exhibited low docking scores, molecular dynamics simulations revealed stable binding over time, with persistent hydrogen bonding and RMSD values around 2.5 Å. RMSF analysis further indicated reduced flexibility at key binding residues, but instability of a residue was observed near the binding site of IRAK-1. Binding free energy calculation indicated that colchicine interacted in energetically more stable than reference compound, but not with IRAK-1, with mean of energy of -47.702±4.417, and -58.451±3.271 for AKT-1 and NF-κB, respectively. These findings suggest that colchicine probably manage inflammation through inhibition of AKT-1 to modulate NF-κB signaling, although experimental validation is required to confirm functional modulation.